CANGRELOR

404 reported adverse events

Drug classes: P2Y12 Platelet Inhibitor [EPC]

These side effects are most commonly reported by patients taking CANGRELOR:

# Side effect Count
0 OFF LABEL USE 160
1 VASCULAR STENT THROMBOSIS 32
2 DRUG INEFFECTIVE 31
3 HAEMORRHAGE 26
4 DEATH 22
5 NO ADVERSE EVENT 20
6 CARDIAC ARREST 18
7 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18
8 CARDIOGENIC SHOCK 15
9 GASTROINTESTINAL HAEMORRHAGE 14
See all common reactions for CANGRELOR

CANGRELOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY VENOUS HYPERTENSION 1 0.0769
1 PLATELET ADHESIVENESS DECREASED 1 0.0769
2 VASCULAR ACCESS SITE HAEMORRHAGE 9 0.0559
3 EOSINOPHIL CATIONIC PROTEIN INCREASED 1 0.0556
4 PROCEDURAL SHOCK 1 0.0278
5 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 2 0.0238
6 PNEUMONIA PSEUDOMONAS AERUGINOSA 1 0.0217
7 CORONARY REVASCULARISATION 3 0.0190
8 RESTENOSIS 1 0.0172
9 ADMINISTRATION SITE INDENTATION 1 0.0161
See all enriched reactions for CANGRELOR